Browsing by Author "Zaman, Raiyan Tripti"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Efficacy of hyper-osmotic agent (100% anhydrous glycerol) in tissue and light-activated micro-pattern drug delivery device in in vivo rabbit eye(2011-05) Zaman, Raiyan Tripti; Rylander, H. Grady (Henry Grady), 1948-; Welch, Ashley J.; Milner, Thomas E.; Zhang, Xiaojing; Vargas, GracieMy PhD research involves multi-disciplinary areas of study such as measuring perfusion of blood vessels in hamster dorsal skin using laser speckle imaging technique. In this study the changes were measured in blood flow velocity and diameters of micro vasculatures after the influence of glycerol application. The second study identifies the changes in morphology and optical properties of eye tissue after applying hyper-osmotic agent such as 100% anhydrous glycerol. Further investigation on the reversal process was performed without any application of 0.9% saline. The third study identified the variation in fluorescence in hamster dorsal skin tissue and enucleated porcine eyes with temperature. This study investigated the variation in fluorescence intensity with temperatures starting at 14°C and compared in vivo and in vitro results for consistency. The fourth study investigated an implantable drug delivery package that was fabricated using PMMA and implanted between the sub-conjunctival and super-scleral space and release the content of the device by either mechanical pressure or light-activated ophthalmic Nd:YAG laser after optically clearing the eye tissue by topical application of a hyper-osmotic agent, 100% anhydrous glycerol. A hyper-osmotic agent creates a transport region in the conjunctiva and sclera to get visual access of the compartments in the drug delivery package. This new technology would provide the option to the patient of one time implantation of the carrier system containing the drug. Each time the patient requires medication a ND-YAG or other laser beam will propagate through the cleared eye tissue to release the drug in measurable doses at the discretion of the doctor from the package directly in to the vitreous humor. In this study we have measured half-life of the dye in the vitreous humor or posterior chamber and biocompatibility. The last study had drawn distinction between the fluorescence signals based on the location (anterior or posterior chamber) of the 10% Na fluorescence dye in the in vivo rabbit and ex vivo pig eyes.Item Measuring nanoparticle concentrations in tissue using diffuse optical spectroscopy(2006-12) Zaman, Raiyan Tripti; Tunnell, James W.; Rylander, H. Grady (Henry Grady), 1948-Metal nanoparticles have recently been demonstrated as combined targeting and therapeutic agents in cancer management. Efforts to design protocols for an effective in vivo therapeutic outcome rely on the knowledge of the nanoparticle localization and concentration; however, a non-invasive in vivo method to determine gold nanoparticle concentration in tissue does not currently exist. In the recent years optical methods are widely being explored as a non-invasive tool for diagnostic and therapeutic applications for various disease conditions. Among various optical techniques, diffuse optical spectroscopy (DOS) is used to quantitatively measure tissue constituents (oxygen saturation, Hb concentration, scattering) in vivo. Hence, the present study was aimed to demonstrate the use of DOS for the non-invasive measurement of nanoparticle concentrations using an inverse algorithm. Preliminary studies were performed on tissue simulating phantoms fabricated from polystyrene beads, intralipid, and hemoglobin. Gold nanoshells at varying concentrations (1.027×10⁸ to 15.40×10⁸ particles/ml) were added to the phantom and the diffuse optical spectra were measured using a fiber optic probe. The gold nanoshell concentration in the tissue-simulating phantom was estimated using the inverse algorithm. In vivo studies were performed on mouse xenograft tumor model. Six to eight weeks old nude mice (n=11) were subcutaneously injected with c6-glioma (rat brain tumor) cells (1×10⁶ cells/injection) in the right flank and the animals were monitored for tumor growth, and they were used for the experiments when the tumor diameter reached approximately 1 cm diameter. Baseline DOS measurements were taken from the tumor spots of all the animals prior to the injection (tail vein) of nanoshells (8x10⁸ nanoshells/g), and the subsequent DOS were measured at 10 s, 1 hr and 24 hr postinjection times. The concentration of nanoshells was estimated as in tissue phantoms. The estimated nanoshell concentrations were correlated with neutron activation analysis (NAA) of the tissue samples extracted at the time points mentioned above. Tissue phantom measurements demonstrated the ability of DOS to extract nanoshell concentrations within the physiologically relevant range. In vivo measurements demonstrated the sensitivity of DOS to detect nanoshell present within the tumor at each of the time points, and these results were confirmed with NAA. These experiments demonstrate the feasibility of DOS to measure gold nanoshell concentrations in vivo. DOS may allow for longitudinal monitoring of gold nanoparticles in in vivo dosimetry and biodistribution studies.